Francom Paula, Robins Morris J
Department of Chemistry and Biochemistry, Brigham Young University, Provo, Utah 84602-5700, USA.
J Org Chem. 2003 Jan 24;68(2):666-9. doi: 10.1021/jo020625a.
Treatment of 9-(2,3,5-tri-O-acetyl-beta-d-ribofuranosyl)-2-amino-6-chloropurine (1) with TMS-Cl and benzyltriethylammonium nitrite (BTEA-NO2) in dichloromethane gave the crystalline 2,6-dichloropurine nucleoside 2, and acetyl chloride/BTEA-NO2 was equally effective ( approximately 85%, without chromatography). TMS-Br/tert-butyl nitrite/dibromomethane gave crystalline 2-bromo-6-chloro analogue 3 (85%). (Chloro or bromo)-dediazoniation of 3',5'-di-O-acetyl-2'-deoxyadenosine (4) gave the 6-[chloro (5, 63%) or bromo (6, 80%)]purine deoxynucleosides, and 2',3',5'-tri-O-acetyladenosine (8) was converted into the 6-chloropurine nucleoside 9 (71%).
在二氯甲烷中,用三甲基氯硅烷(TMS-Cl)和苄基三乙基氯化铵亚硝酸酯(BTEA-NO₂)处理9-(2,3,5-三-O-乙酰基-β-D-呋喃核糖基)-2-氨基-6-氯嘌呤(1),得到结晶状的2,6-二氯嘌呤核苷2,乙酰氯/BTEA-NO₂同样有效(约85%,无需色谱分离)。三甲基溴硅烷/叔丁基亚硝酸酯/二溴甲烷得到结晶状的2-溴-6-氯类似物3(85%)。3',5'-二-O-乙酰基-2'-脱氧腺苷(4)的(氯或溴)脱重氮化反应得到6-[氯(5,63%)或溴(6,80%)]嘌呤脱氧核苷,并且2',3',5'-三-O-乙酰基腺苷(8)转化为6-氯嘌呤核苷9(71%)。